Akero Therapeutics, Inc.
US ˙ NasdaqGS ˙ US00973Y1082
TEN SYMBOL NIE JEST JUŻ AKTYWNY

SecurityAKRO / Akero Therapeutics, Inc.
InstitutionRYDEX VARIABLE TRUST - Biotechnology Fund Variable Annuity
Latest Disclosed Ownership1,599 shares
Latest Disclosed Value $ 85,322
RYDEX VARIABLE TRUST - Biotechnology Fund Variable Annuity ownership in AKRO / Akero Therapeutics, Inc.

On August 27, 2025 - RYDEX VARIABLE TRUST - Biotechnology Fund Variable Annuity filed a NPORT-P form disclosing ownership of 1,599 shares of Akero Therapeutics, Inc. (US:AKRO) valued at $85,323 USD as of June 30, 2025. The entity filed a previous NPORT-P on March 3, 2025 disclosing 0 shares of Akero Therapeutics, Inc.. The current value of the position is $87,385 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-08-27 2025-06-30 NP Akero Therapeutics EC US00973Y1082 1,599 1,599 85 0.9482
2025-03-03 2024-12-31 NP Akero Therapeutics EC US00973Y1082 0 -1,778 -100.00 0 -100.00
2024-11-29 2024-09-30 NP Akero Therapeutics EC US00973Y1082 1,778 -784 -30.60 51 -15.00 0.4620
2024-08-29 2024-06-30 NP Akero Therapeutics EC US00973Y1082 2,562 353 15.98 60 9.09 0.5480
2024-05-30 2024-03-31 NP Akero Therapeutics EC US00973Y1082 2,209 -633 -22.27 56 -16.67 0.4732
2024-02-29 2023-12-31 NP Akero Therapeutics EC US00973Y1082 2,842 2,842 66 0.5439
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.